Board of Advisors
Bob Mackey joined the Bend Biomedical Board of Advisors in 2024, bringing with him a wealth of experience in the pharmaceutical and biotechnology industries. Currently serving as the Senior Vice President of Global Commercial Development and Planning at Jazz Pharmaceuticals, Bob plays a key role in shaping the company’s strategic direction and market approach. His extensive background spans over 15 years in new product planning and product management, where he has been instrumental in driving successful launches and maximizing product potential.
Before his current position, Bob spent three years in managed care marketing, honing his skills in navigating complex healthcare environments to effectively promote pharmaceutical products. He has been involved in numerous deal teams throughout his career, showcasing his expertise in building strategic partnerships and collaborations. Additionally, Bob has three years of experience in sales and sales management, which has further strengthened his understanding of the commercial landscape and the importance of effective communication in driving business success.
Bob’s educational journey began at the University of California, Berkeley, where he earned a Bachelor of Arts degree in Biology. He furthered his education with an MBA in Business and Marketing from Duke University. His professional career includes significant roles at well-known companies, including Burroughs Wellcome, Alza Pharmaceuticals, Genentech, Scios/J&J, and Tercica/Ipsen. Each of these positions has contributed to his comprehensive understanding of the pharmaceutical industry and his ability to lead teams in launching new products.
With specialties in branding, pricing, distribution, managed care, and leading launch teams, Bob is well-equipped to provide strategic insights to Bend Biomedical. His commitment to improving global health aligns with the organization’s mission to deliver quality medicines to neglected populations. Bob’s vast knowledge and experience make him a valuable asset to the Board of Advisors, where he aims to contribute to the ongoing efforts of Bend Biomedical to impact healthcare positively.